Upcoming Dividend Alert! Glenmark Pharma Board To Consider Dividend On Sept 26; Check Dividend Record Date

Upcoming Dividend Alert: Glenmark Pharmaceuticals Limited's board of directors will consider and approve interim dividend for the financial year 2025-26 in the last week of September, the company announced on Monday. Additionally, Glenmark Pharma dividend record date has been fixed as October 4.

Glenmark Pharmaceuticals shares ended 0.20% higher at Rs 2018.3 per share on BSE with a market capitalisation of Rs 56,956.59 crore. The stock has a return on equity (RoE) of 6.21%.

Glenmark Pharmaceuticals Dividend Announcement

The company, on Monday, announced that its board of directors will consider and approve the dividend (if any) in its meeting, scheduled to be held on Friday, September 27. "The Board of Directors scheduled on Friday, September 26, 2025, to consider and approve payment of an interim dividend, if any, on Equity Shares of the Company for the financial year 2025-26," noted the company in its BSE filing.

Glenmark Pharma Dividend Record Date

The company had also announced the dividend record date to determine the eligibility of shareholders for the corporate action. The company, earlier on Monday, had fixed 30 September as the dividend record date. However, later in the day, the dividend record date was revised to October 3.

Glenmark Pharma Share Price Trend

The stock ended higher at Rs 2018 per share on BSE on Tuesday. The stock had touched a 52-week high mark of Rs 2,286.15 per share on 11 July, 2025. The stock had dipped to its 52-week low mark of Rs 1,274.70 on 2 February, 2025.
The stock valuation has increased 25% year to date (YTD). Its valuation has surged around 151% in two years. The stock price valuation has increased around 17.93 in one year.

Glenmark Pharma Q1 Result

The company had reported a significant drop in its net profit in the first quarter of financial year 2025-26. Glenmark Pharma's profit fell by 86.2% year-on-year to Rs46.8 crore from Rs 340.2 crore in Q1FY25. Despite this decline, revenue saw a slight increase of 0.6%, reaching ₹3,264 crore compared to ₹3,244 crore in the same period last year.
The company's EBITDA decreased by 1.4% to Rs 580 crore during this quarter compared to Rs 588.2 crore in the previous year. The EBITDA margin also declined slightly to 17.7% from 18.1% in the April-July quarter of the previous fiscal year.